Saturday, July 11, 2026

pharma · Pterygium · Open Angle Glaucoma

Zhongshan Ophthalmic Center

Zhongshan Ophthalmic Center is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pterygium, Open Angle Glaucoma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 paten

Guangzhou, CN HQ
85 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Guangzhou, CN
Employees
85
Programs
2
Drugs
5
Patents
0
Clinical program

Routine IOP-lowering medications

Unknown · small molecule · Open Angle Glaucoma

Routine IOP-lowering medications for Open Angle Glaucoma is a Unknown program (small_molecule) at Zhongshan Ophthalmic Center, Sun Yat-sen University with 1 ClinicalTrials.gov record(s).

Internal code 2020KYPJ108

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Unknown
Modality
small_molecule
Indication
Open Angle Glaucoma
Status
active
Trials
1